Original Research

Accepted on 29 Nov 2024

Identification and validation the predictive biomarkers based on riskadjusted control chart in Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy

in Cancer Genetics and Oncogenomics

Aijun Zhao
Dongsheng Tu
Ye He
Liu Liu
Bin Wu
Yixing Ren

Frontiers in Genetics

doi 10.3389/fgene.2024.1497254

Review

Published on 29 Nov 2024

PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for

in Cancer Genetics and Oncogenomics

Sara Parola
Christoph Oing
Pasquale Rescigno
Salvatore Feliciano
Francesca Carlino
Luca Pompella
Antonella Lucia Marretta
Irene De Santo
Martina Viggiani
Margherita Muratore

Frontiers in Genetics

doi 10.3389/fgene.2024.1480417

109 views

Original Research

Published on 29 Nov 2024

Gradient boosting reveals spatially diverse cholesterol gene signatures in colon cancer

in Cancer Genetics and Oncogenomics

Xiuxiu Yang
Debolina Chatterjee
Justin L. Couetil
Ziyu Liu
Valerie D. Ardon
Chao Chen
Jie Zhang
Kun Huang
Travis S. Johnson

Frontiers in Genetics

doi 10.3389/fgene.2024.1410353

226 views

Original Research

Published on 27 Nov 2024

Exploring the therapeutic potency of cryptotanshinone in cervical cancer: a multi-omics and network pharmacology approach

in Cancer Genetics and Oncogenomics

Zenghong Lu
Gangfeng Zhu
Xiaofei Feng
Yi Xiang
Cixiang Chen
Huiting Yuan
Zhixing Chen

Frontiers in Genetics

doi 10.3389/fgene.2024.1435132

285 views

Original Research

Accepted on 26 Nov 2024

Integration of single-cell and bulk analysis reveals TBXAS1 as a key platelet-related gene causing poor prognosis in osteosarcoma

in Cancer Genetics and Oncogenomics

Han Liu
Wacili Da
Jianhua Mu
Xuanhong He
Li Zhuangzhuang
Taojun Gong
Jingjing Wang
Li Min
Minxun Lu
Chongqi Tu

Frontiers in Genetics

doi 10.3389/fgene.2024.1519529

Original Research

Accepted on 26 Nov 2024

Real-World Efficacy and Safety of Combined First-Line Treatment with PARP Inhibitors and Novel Hormonal Therapy in mCRPC Patients with HRR

in Cancer Genetics and Oncogenomics

Andong Guo
Chenrui Wu
Jishuang Cao
Kejia Zhu
Sentai Ding

Frontiers in Genetics

doi 10.3389/fgene.2024.1505163

Review

Accepted on 26 Nov 2024

Viral Infection, APOBEC3 Dysregulation, and Cancer

in Cancer Genetics and Oncogenomics

Jake Lehle
Mohadeseh Soleimanpour Moghadam
Samira Mokhtari
Diako Ebrahimi

Frontiers in Genetics

doi 10.3389/fgene.2024.1489324

Review

Accepted on 26 Nov 2024

Dysregulation of Ubiquitination modification in Renal Cell Carcinoma

in Cancer Genetics and Oncogenomics

Hongjie You
Hui Zhang
Xiaofeng Jin
Zejun Yan

Frontiers in Genetics

doi 10.3389/fgene.2024.1453191

Original Research

Published on 22 Nov 2024

Holliday junction recognition protein (HJURP) could reflect the clinical outcomes of lung adenocarcinoma patients, and impact the choice of precision therapy

in Cancer Genetics and Oncogenomics

Xixi Gao
Yingqing Zhang
Ming Zhang
Yuejiao Sun

Frontiers in Genetics

doi 10.3389/fgene.2024.1475511

256 views

Original Research

Published on 22 Nov 2024

Bioinformatics insights into the role of GFPT1 in breast invasive carcinoma: implications for tumor prognosis, immune modulation, and therapeutic applications

in Cancer Genetics and Oncogenomics

Jianghui Liang
Xiaolian Deng
Yingyi Zhang
Tianchi Fei
Muzi Ouyang
Chengjie Yu
Yang Xiang
Dongwei Jia
Fangfang Duan

Frontiers in Genetics

doi 10.3389/fgene.2024.1482929

232 views

Correction

Accepted on 21 Nov 2024

Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

in Cancer Genetics and Oncogenomics

Haiyang Zhao
Kexin Luo
Meihan Liu
Yuanze Cai
Siman Liu
Shijuan Li
Yongsheng Zhao
Hongpan Zhang

Frontiers in Genetics

doi 10.3389/fgene.2024.1531321

Original Research

Accepted on 19 Nov 2024

BIRC5 as a Prognostic and Diagnostic Biomarker in Pan-Cancer: An Integrated Analysis of Expression, Immune Subtypes, and Functional Networks

in Cancer Genetics and Oncogenomics

Guoyu Li
Yanghao Wang
Wei-zhou Wang
Guodong Lv
Xiang Li
Jingying Wang
Xiuyu Liu
Daolang Yuan
Shoujun Deng
Dingyun You

Frontiers in Genetics

doi 10.3389/fgene.2024.1509342

Original Research

Accepted on 19 Nov 2024

Exploring the Impact of Deubiquitination on Melanoma Prognosis Through Single-Cell RNA Sequencing

in Cancer Genetics and Oncogenomics

Su Peng
Jiaheng Xie
Xiaohu He

Frontiers in Genetics

doi 10.3389/fgene.2024.1509049

Original Research

Published on 14 Nov 2024

A scoring model based on bacterial lipopolysaccharide-related genes to predict prognosis in NSCLC

in Cancer Genetics and Oncogenomics

Nandi Bao
Xinxin Zhang
Chenyu Lin
Feng Qiu
Guoxin Mo

Frontiers in Genetics

doi 10.3389/fgene.2024.1408000

407 views

Original Research

Published on 23 Oct 2024

Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

in Cancer Genetics and Oncogenomics

Haiyang Zhao
Kexin Luo
Meihan Liu
Yuanze Cai
Siman Liu
Shijuan Li
Yongsheng Zhao
Hongpan Zhang

Frontiers in Genetics

doi 10.3389/fgene.2024.1458047

831 views

Original Research

Published on 22 Oct 2024

Elucidating macrophage scavenger receptor 1’s mechanistic contribution as a shared molecular mediator in obesity and thyroid cancer pathogenesis via bioinformatics analysis

in Cancer Genetics and Oncogenomics

Fangjian Shang
Zhe Xu
Haobo Wang
Bin Xu
Ning Li
Jiakai Zhang
Xuan Li
Zhen Zhao
Xi Zhang
Bo Liu

Frontiers in Genetics

doi 10.3389/fgene.2024.1483991

651 views

Navigation group

Articles

Identification and validation the predictive biomarkers based on riskadjusted control chart in Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy

PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for

Gradient boosting reveals spatially diverse cholesterol gene signatures in colon cancer

Exploring the therapeutic potency of cryptotanshinone in cervical cancer: a multi-omics and network pharmacology approach

Integration of single-cell and bulk analysis reveals TBXAS1 as a key platelet-related gene causing poor prognosis in osteosarcoma

Real-World Efficacy and Safety of Combined First-Line Treatment with PARP Inhibitors and Novel Hormonal Therapy in mCRPC Patients with HRR

Viral Infection, APOBEC3 Dysregulation, and Cancer

Dysregulation of Ubiquitination modification in Renal Cell Carcinoma

Holliday junction recognition protein (HJURP) could reflect the clinical outcomes of lung adenocarcinoma patients, and impact the choice of precision therapy

Bioinformatics insights into the role of GFPT1 in breast invasive carcinoma: implications for tumor prognosis, immune modulation, and therapeutic applications

Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

BIRC5 as a Prognostic and Diagnostic Biomarker in Pan-Cancer: An Integrated Analysis of Expression, Immune Subtypes, and Functional Networks

Exploring the Impact of Deubiquitination on Melanoma Prognosis Through Single-Cell RNA Sequencing

A scoring model based on bacterial lipopolysaccharide-related genes to predict prognosis in NSCLC

Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

Elucidating macrophage scavenger receptor 1’s mechanistic contribution as a shared molecular mediator in obesity and thyroid cancer pathogenesis via bioinformatics analysis